Triple
T4050921
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Gilead Sciences |
E84182
|
entity |
| Predicate | developed |
P73
|
FINISHED |
| Object |
velpatasvir
Velpatasvir is a direct-acting antiviral medication used in combination with sofosbuvir to treat chronic hepatitis C virus infection across multiple genotypes.
|
E409693
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69aed930bd5c819083e7dcc14fc44f69 |
elicitation | completed |
| NER | batch_69aefb8539148190990468c1429be9dd |
ner | completed |
| NED1 | batch_69b55659256081909154569cedd1694a |
ned_source_triple | completed |
| NED2 | batch_69b55b333ffc8190a5df8b8d7bffa77f |
ned_description | completed |
| NEDg | batch_69b5572b27c48190989311cef00b5f44 |
nedg | completed |
Created at: March 9, 2026, 3:37 p.m.